NCT07096973 Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery
| NCT ID | NCT07096973 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hochgebirgsklinik Davos |
| Condition | Cardiac Rehabilitation |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2025-08-05 |
| Primary Completion | 2035-08-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2025-08-05 with a primary completion date of 2035-08-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The RECOVER study, titled Cardiac Rehabilitation Cohort at the Medicine Campus Davos for Exploration of Recovery, is a prospective, non-interventional, monocentric cohort study conducted at the Hochgebirgsklinik Davos. The study is sponsored by Medicine Campus Davos AG and the Kühne Foundation, with an estimated start date in July 2025 and planned completion by December 2034, with the possibility of extension. The principal investigator of the study is PD Dr. David Niederseer from Hochgebirgsklinik Davos, who also represents the study. The research team includes co-investigators such as Prof. Dr. Stefan Blankenberg and Prof. Dr. Andreas Ziegler from Cardio-CARE, Medicine Campus Davos, as well as Dr. Jan Vontobel from Hochgebirgsklinik Davos. The study will enroll patients referred to Hochgebirgsklinik Davos for cardiac rehabilitation who provide informed consent. Cardiac rehabilitation is an evidence-based therapy for patients with heart disease, including those who have undergone cardiac procedures or surgeries. The primary objectives are to evaluate baseline patient characteristics, rehabilitation strategies, predictors of recovery, and clinical outcomes during and after rehabilitation. To support this, a detailed database and biobank will be established to allow for comprehensive phenotyping, extensive clinical assessments, and long-term follow-up. RECOVER seeks to gain translational insights into how patient-specific factors - such as genetics, plasma, digital and clinical biomarkers, and comorbidities - influence long-term clinical outcomes. The goal is to identify modifiable risk factors to optimize individualized therapeutic approaches in cardiac rehabilitation.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing CR at the HGK * Written informed consent * Age ≥ 18 years Exclusion Criteria: * Insufficient knowledge of the German language to understand study documents, the interview, or questionnaires interview without translation * Physical or psychological incapability to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07096973 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07096973 currently recruiting?
Yes, NCT07096973 is actively recruiting participants. Contact the research team at research@hgk.ch for enrollment information.
Where is the NCT07096973 trial being conducted?
This trial is being conducted at Davos, Switzerland.
Who is sponsoring the NCT07096973 clinical trial?
NCT07096973 is sponsored by Hochgebirgsklinik Davos. The trial plans to enroll 10,000 participants.